| 000 | 01391 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513102640.0 | ||
| 264 | 0 | _c19961115 | |
| 008 | 199611s 0 0 fre d | ||
| 022 | _a0007-4551 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRiedinger, J M | |
| 245 | 0 | 0 |
_a[Prognostic value of CA 125 initial half-life measured during first-line chemotherapy in 62 patients with epithelial ovarian cancer stage III or IV]. _h[electronic resource] |
| 260 |
_bBulletin du cancer _cAug 1996 |
||
| 300 |
_a654-63 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAntigens, Tumor-Associated, Carbohydrate _xblood |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aBarillot, I | |
| 700 | 1 | _aCoudert, B | |
| 700 | 1 | _aFargeot, P | |
| 700 | 1 | _aBerriolo-Riedinger, A | |
| 700 | 1 | _aGuerrin, J | |
| 773 | 0 |
_tBulletin du cancer _gvol. 83 _gno. 8 _gp. 654-63 |
|
| 999 |
_c8861831 _d8861831 |
||